These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 17204908
1. Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies? Heringer-Walther S, Moreira Mda C, Wessel N, Wang Y, Ventura TM, Schultheiss HP, Walther T. J Cardiovasc Pharmacol; 2006 Dec; 48(6):293-8. PubMed ID: 17204908 [Abstract] [Full Text] [Related]
2. Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation. Moreira Mda C, Heringer-Walther S, Wessel N, Moreira Ventura T, Wang Y, Schultheiss HP, Walther T. Cardiology; 2008 Dec; 110(4):217-25. PubMed ID: 18073475 [Abstract] [Full Text] [Related]
3. Prognostic value of natriuretic peptides in Chagas' disease: a head-to-head comparison of the 3 natriuretic peptides. Moreira Mda C, Wang Y, Heringer-Walther S, Wessel N, Walther T. Congest Heart Fail; 2009 Dec; 15(2):75-81. PubMed ID: 19379453 [Abstract] [Full Text] [Related]
9. Prognostic significance of circulating levels of hepatocyte growth factor in patients with chagas' disease and idiopathic dilated cardiomyopathy. Wang Y, Moreira Mda C, Khan A, Heringer-Walther S, Schultheiss HP, Wessel N, Siems WE, Walther T. Cardiology; 2012 Dec; 121(4):240-6. PubMed ID: 22555361 [Abstract] [Full Text] [Related]
11. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy. Squire IB, Ørn S, Ng LL, Manhenke C, Shipley L, Aarsland T, Dickstein K. J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243 [Abstract] [Full Text] [Related]
12. Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy. Sarli B, Topsakal R, Kaya EG, Akpek M, Lam YY, Kaya MG. J Investig Med; 2013 Apr; 61(4):728-32. PubMed ID: 23429699 [Abstract] [Full Text] [Related]
13. Clinical course and risk profile in adolescents with idiopathic dilated cardiomyopathy. Limongelli G, Pacileo G, Ancona R, Eusebio G, D'Andrea A, Romano M, Di Salvo G, Rea A, Calabró P, Romano G, Maiello C, Calabró R. Am J Cardiol; 2010 Mar 01; 105(5):716-20. PubMed ID: 20185022 [Abstract] [Full Text] [Related]
14. Improvement in left ventricular diastolic stiffness induced by physical training in patients with dilated cardiomyopathy. Malfatto G, Branzi G, Osculati G, Valli P, Cuoccio P, Ciambellotti F, Parati G, Facchini M. J Card Fail; 2009 May 01; 15(4):327-33. PubMed ID: 19398081 [Abstract] [Full Text] [Related]
15. Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy. Avci A, Alizade E, Fidan S, Yesin M, Guler Y, Kargin R, Esen AM. Scand Cardiovasc J; 2014 Aug 01; 48(4):202-8. PubMed ID: 24912526 [Abstract] [Full Text] [Related]
19. Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction. Del Ry S, Giannessi D, Maltinti M, Prontera C, Iervasi A, Colotti C, Emdin M, L'Abbate A, Neglia D. Peptides; 2007 May 01; 28(5):1068-73. PubMed ID: 17428580 [Abstract] [Full Text] [Related]